Navigation Links
Global Demand for Pharmaceutical Regulatory Specialists Escalating Rapidly
Date:9/26/2013

Willow Grove, PA (PRWEB) September 26, 2013

Pharmaceutical companies are under considerable top-line and bottom-line pressure as the industry grapples with a significant wave of patent expirations, shrinking product pipelines and increasing generic competition. As pharmaceutical businesses look for ways to combat the resulting revenue loss, the ability to maximize revenues from international markets has becoming more important than ever. This environment is creating increased demand for professionals with global regulatory strategy experience, according to Klein Hersh International, a leading executive recruitment firm in the life sciences industry. As an exhibitor at the upcoming Regulatory Convergence, hosted by the Regulatory Affairs Professionals Society (RAPS), on September 28 – October 2, 2013 in Boston, MA, Klein Hersh seeks to help companies recruit industry-leading, regulatory affairs professionals for both full-time hiring needs and for consulting or contract engagements.

“Increasingly, companies are looking for regulatory affairs professionals with truly global experience, anchored with strong US or EU experience,” says Colin Dittus, senior director and practice leader, regulatory affairs at Klein Hersh. “We’re seeing this demand equally in both our Recruiting and Contract Staffing businesses.”

“More than ever, we’re also seeing intense scrutiny of intangible qualities for regulatory hires – especially leadership. Clients want professionals who not only have the requisite experience and knowledge, but who are also able to effectively lead project teams through difficult regulatory hurdles, and influence across multi-disciplined project teams.”

“Even for non-supervisory hires”, Dittus says, “regulatory professionals who are either naturally strong influencers and communicators, or those who have worked hard to develop these critical skills are navigating the interview process more effectively than their peers who are not as adept in these areas.”    

Further complicating the situation, points out Dittus, is that the increased scrutiny comes at a time when demand is on the rise. “Our mission is to help pharmaceutical companies navigate the complexities of the job market,” says Dittus. “Desirable candidates are almost always going to have multiple opportunities to consider. The key to making great hires is taking a long-term approach to develop deep insight, on an individual level, into personal, professional and financial motivations and goals. Clients value this approach for two reasons. First, the end result is a faster hire because much of the recruiting process has already happened ahead of the need. Second, the match is stronger and results in better long-term fit.

The high unemployment that plagues some industries is not apparent in the pharmaceutical regulatory sector, maintains Dittus. “We have had to beef up our own capabilities by adding to our recruitment team in order to best serve our clients,” he observes. “This in itself is reflective of the uptick in demand.”

# # #

About Klein Hersh International:
For fifteen years, recruiters at Klein Hersh International have delivered strategic leadership placement solutions to the world’s leading pharmaceutical and biotechnology companies. With an exclusive focus on the life sciences industry, including the complete drug development life cycle, Klein Hersh places over 400 professionals each year. For more information, visit http://www.kleinhersh.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11163697.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... firm Parks Associates announced today that Tom Kerber , ... Meeting , October 11 in Scottsdale, Arizona . Kerber ... smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings ... mechanism by which its ProCell stem cell therapy ... limb ischemia.  The Company, demonstrated that treatment with ... of limbs saved as compared to standard bone ... molecule HGF resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... Texas (PRWEB) , ... October ... ... study published on October 5, 2017, in the medical journal, Epilepsia, Brain ... with the gold standard, video EEG, in detecting generalized tonic-clonic seizures (GTCS) ...
(Date:10/6/2017)... (PRWEB) , ... October 06, 2017 , ... ... entrepreneurship within the healthcare and technology sector at their fourth annual Conference where ... featuring 30 inspiring speakers and the ELEVATE pitch competition showcasing early stage digital ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
Breaking Biology News(10 mins):